Detalles de la búsqueda
1.
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.
J Neurol Neurosurg Psychiatry;
94(9): 757-768, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37221052
2.
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker.
Ann Neurol;
89(5): 895-910, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33724534
3.
Pharmacodynamic modelling and exposure-response assessment of inebilizumab in subjects with neuromyelitis optica spectrum disorders.
Br J Clin Pharmacol;
88(8): 3803-3812, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35332558
4.
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study.
Gastroenterology;
153(1): 77-86.e6, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28390867
5.
Clinical pharmacology of AMG 181, a gut-specific human anti-α4ß7 monoclonal antibody, for treating inflammatory bowel diseases.
Br J Clin Pharmacol;
78(6): 1315-33, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24803302
6.
Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism.
Ann Clin Transl Neurol;
10(12): 2413-2420, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37804003
7.
Population Pharmacokinetic Modeling of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders, Systemic Sclerosis, or Relapsing Multiple Sclerosis.
Clin Pharmacokinet;
61(3): 387-400, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34718986
8.
Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial.
EBioMedicine;
86: 104321, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36370634
9.
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus.
Sci Transl Med;
13(595)2021 05 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34039741
10.
Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus.
Sci Rep;
10(1): 4462, 2020 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32157125
11.
A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system.
J Clin Pharmacol;
48(5): 580-91, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18319361
12.
A quantitative description of the binding states and in vitro function of antitermination protein N of bacteriophage lambda.
J Mol Biol;
348(5): 1039-57, 2005 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15854643
13.
Prediction of clinical pharmacokinetics of AMG 181, a human anti-α 4 ß 7 monoclonal antibody for treating inflammatory bowel diseases.
Pharmacol Res Perspect;
3(1): e00098, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25692016
14.
Stronger correlation of bcl-3 than bcl-2, bcl-xL, costimulation, or antioxidants with adjuvant-induced T cell survival.
Ann N Y Acad Sci;
975: 114-31, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12538159
15.
Bridging the Divide between Manual Gating and Bioinformatics with the Bioconductor Package flowFlowJo.
Adv Bioinformatics;
: 809469, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19956421
Resultados
1 -
15
de 15
1
Próxima >
>>